Dendritic Cell Vaccine, AV-COVID-19, to Prevent COVID-19 Infection
COVID-19This is an adaptive Phase I trial of a vaccine consisting of autologous dendritic cells previously loaded ex vivo with SARS-CoV-2 spike protein, with or without GM-CSF, to prevent COVID-19 in adults.
A Study to Evaluate the Safety and Immunogenicity of Vaccine CVnCoV in Healthy Adults in Germany...
CoronavirusCovid192 moreThis study aims to evaluate the safety (in all participants) and reactogenicity (in a subset of participants) of CVnCoV administered as a 2-dose schedule to adult participants 18 years of age or older. The study also aims to assess antibody responses to the receptor-binding domain (RBD) of spike (S) protein of SARS-CoV-2 after 1 and 2 doses of CVnCoV in adults 18 years of age or older included in a subset of participants.
Evaluation of Immunogenicity and Safety of COVID-19 Vaccine (Produced in Beijing) in Patients With...
COVID-19 PneumoniaTo evaluate the post-marketing immunogenicity and safety of the inactivated severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine (Vero cells) in patients aged 60 years or older with hypertension and/or diabetes, thus to further collect the immunogenicity and safety data of this product in special populations.
A Study to Evaluate MVC-COV1901 Vaccine Against COVID-19 in Adolescents
Covid19 VaccineThe purpose of this study is to assess the safety and immunogenicity of MVC-COV1901 vaccine compared to placebo in participants aged ≥ 12 to < 18 years.
SARS-CoV-2 Immune Responses After COVID-19 Therapy and Subsequent Vaccine
Covid19SARS-CoV2 InfectionThe purpose of this study is to evaluate the safety and efficacy of mRNA COVID-19 vaccines in: • People with prior COVID-19 (SARS-CoV-2 infection) who were in the ACTIV-2/A5401 study. And • People who have never had COVID-19 (SARS-CoV-2 infection).
Phase II/III Study of AZD2816, for the Prevention of COVID-19 in Adults
COVID-19SARS-CoV-2The aim of the study is to assess the safety, and immunogenicity of AZD2816 for the prevention of COVID-19
The Immune Reaction Upon COVID-19 Vaccination in the Belgian Cancer Population.
CancerThis study investigates the immune response in the cancer population in Belgium being vaccinated with an approved vaccine types being authorized for use in Belgium. This question needs to be answered to make sure that this vulnerable population is properly protected against possible SARS-CoV-2 infection and that vaccine administration is safe.
Safety and Immunogenicity Study of AdCLD-CoV19-1: A COVID-19 Preventive Vaccine in Healthy Volunteers...
Covid19This is a Phase 1 clinical trial to assess the safety and immunogenicity of AdCLD-CoV19-1 in healthy adults.
Study of the Use of Nasal IFN-γ in Patients for the Prevention of Acute Respiratory Viral Infections,...
COVID-19 Respiratory InfectionAcute Respiratory DiseaseIt is known that the pretreatment with exogenous interferon blocks SARS-CoV-2 infection, but intervention is much more effective if administered prior to infection. In this study the primary aim is to investigate 28-day regime of nasal interferon gama use in healthy participants for COVID-19 and other respiratory infections prevention.
Rosmalip® for Cancer Infections Prevention
InfectionsCovid191 moreThis study is designed to assess the safety and efficacy of Rosmalip® nutritional supplement compared to placebo in subjects with solid cancer for the prevention of infections including COVID-19.